(NASDAQ: ALVO) Alvotech's forecast annual revenue growth rate of 49.83% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,776.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.
Alvotech's revenue in 2026 is $573,350,000.On average, 6 Wall Street analysts forecast ALVO's revenue for 2026 to be $267,684,087,355, with the lowest ALVO revenue forecast at $248,648,372,857, and the highest ALVO revenue forecast at $283,046,024,247.
In 2027, ALVO is forecast to generate $340,268,460,168 in revenue, with the lowest revenue forecast at $303,293,867,234 and the highest revenue forecast at $363,638,546,718.